Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2004

View Archived Issues

Sepracor highlights year-end 2003 progress

T-0901317 induces severe lipogenesis in diabetic mice

Novel selective cytokine inhibitory drugs demonstrate enhanced antiangiogenic activity

Novel protease inhibitor SM-322377 active against multidrug-resistant HIV variants

Cleveland Clinic and Ricerca to develop cobalamin-based anticancer compound

SU-11248 inhibits tumor growth and osteolysis in a human breast cancer bone metastasis model

Altana researchers present two novel series of PARP-1 inhibitors

Procter & Gamble claims ICE inhibitors for bone disorders and other uses

GSK scientists identify new cathepsin K/falcipain inhibitors

Takeda patent covers novel tachykinin antagonists with utility in urinary disorders

New antitumor agents developed by RIKEN scientists

NO-containing COX-2 inhibitors in early development at NitroMed

Glycine transport inhibitors from bacterial source and their use in ataxia

Merck and Jerini to develop small molecule inhibitors for cancer

Tanabe gains Japanese rights to prasterone

Pfizer submits sNDA for Geodon product label changes

NeoRx receives payment from Boston Scientific

Rapid absorption, high plasma concentrations in phase I nasal fentanyl study

Activa Therapy more effective than pallidotomy in Parkinson's patients

Betaseron prefilled diluent syringe launched in U.S.

Phase III Thymitaq trial cleared to continue by DSMB

Lilly reacts to opinion paper on antipsychotic drugs in obesity and diabetes

Initial proof-of-concept study successfully completed for Provasca

Rigel reports on the progress of R-803, R-406

European orphan drug status for sildenafil for PAH

Provectus prepares IND filing for Provecta

Launch of Zoderm acne treatment

Xcytrin enters phase I trial in combination with Temodar for glioma

Viral Therapeutics acquires development rights to Virusorb

Lipid profile improvements found with D-003 in patients with type II hypercholesterolemia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...